Next Article in Journal
Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction—A Pilot Study
Next Article in Special Issue
Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
Previous Article in Journal
Anatomy of Major Duodenal Papilla Influences ERCP Outcomes and Complication Rates: A Single Center Prospective Study
Previous Article in Special Issue
Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease
Open AccessReview

Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease

1
Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, 41013 Seville, Spain
2
CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28029 Madrid, Spain
3
Pneumology Department, Hospital Universitari Vall d’Hebron/Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, 08035 Barcelona, Spain
4
Pneumology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain
5
Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain
6
Pneumology, Hospital Arnau de Villanova-Lliria, 46015 Valencia, Spain
7
Pneumology Department, Universitary and Polytechnic La Fe Hospital, 46015 Valencia, Spain
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(6), 1639; https://doi.org/10.3390/jcm9061639
Received: 30 April 2020 / Revised: 21 May 2020 / Accepted: 22 May 2020 / Published: 28 May 2020
Currently, chronic obstructive pulmonary disease (COPD) patients and their physicians face a number of significant clinical challenges, one of which is the high degree of uncertainty related to chronic bronchial infection (CBI). By reviewing the current literature, several challenges can be identified, which should be considered as goals for research. One of these is to establish the bases for identifying the biological and clinical implications of the presence of potentially pathogenic microorganisms in the airways that should be more clearly elucidated according to the COPD phenotype. Another urgent area of research is the role of long-term preventive antibiotics. Clinical trials need to be carried out with inhaled antibiotic therapy to help clarify the profile of those antibiotics. The role of inhaled corticosteroids in patients with COPD and CBI needs to be studied to instruct the clinical management of these patients. Finally, it should be explored and confirmed whether a suitable antimicrobial treatment during exacerbations may contribute to breaking the vicious circle of CBI in COPD. The present review addresses the current state of the art in these areas to provide evidence which will enable us to progressively plan better healthcare for these patients. View Full-Text
Keywords: COPD; potentially pathogenic microorganism; chronic bronchial infection COPD; potentially pathogenic microorganism; chronic bronchial infection
Show Figures

Graphical abstract

MDPI and ACS Style

Lopez-Campos, J.L.; Miravitlles, M.; de la Rosa Carrillo, D.; Cantón, R.; Soler-Cataluña, J.J.; Martinez-Garcia, M.A. Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease. J. Clin. Med. 2020, 9, 1639.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop